These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26823152)

  • 1. Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.
    Colantonio LD; Kent ST; Kilgore ML; Delzell E; Curtis JR; Howard G; Safford MM; Muntner P
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):827-35. PubMed ID: 26823152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement of claims-based methods for identifying sepsis with clinical criteria in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
    Donnelly JP; Dai Y; Colantonio LD; Zhao H; Safford MM; Baddley JW; Muntner P; Wang HE
    BMC Med Res Methodol; 2020 Mar; 20(1):54. PubMed ID: 32131746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.
    Adams AS; Madden JM; Zhang F; Soumerai SB; Gilden D; Griggs J; Trinacty CM; Bishop C; Ross-Degnan D
    Med Care; 2014 Aug; 52(8):695-703. PubMed ID: 24988304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.
    Mark TL; Axelsen KJ; Mucha L; Sadkova Y
    Am J Manag Care; 2007 Jun; 13 Suppl 3():S72-9. PubMed ID: 17596115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients.
    Polinski JM; Schneeweiss S; Levin R; Shrank WH
    Clin Ther; 2009 Sep; 31(9):2048-59. PubMed ID: 19843494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.
    Young JC; Stürmer T; Lund JL; Funk MJ
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):836-43. PubMed ID: 26991151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
    Thorpe CT; Fowler NR; Harrigan K; Zhao X; Kang Y; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM
    J Am Geriatr Soc; 2016 Sep; 64(9):1806-14. PubMed ID: 27549029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
    Adams AS; Madden JM; Zhang F; Lu CY; Ross-Degnan D; Lee A; Soumerai SB; Gilden D; Chawla N; Griggs JJ
    Value Health; 2017 Dec; 20(10):1345-1354. PubMed ID: 29241894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.
    Zhou L; Stearns SC; Thudium EM; Alburikan KA; Rodgers JE
    Med Care; 2015 May; 53(5):463-70. PubMed ID: 25793271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic group variations in service use in a national sample of Medicare home health care patients with type 2 diabetes mellitus.
    Yeboah-Korang A; Kleppinger A; Fortinsky RH
    J Am Geriatr Soc; 2011 Jun; 59(6):1123-9. PubMed ID: 21649625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study.
    Feng JL; Qin X
    Eur J Clin Pharmacol; 2021 Mar; 77(3):399-407. PubMed ID: 33030570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of selection bias in the association of race with prevalent atrial fibrillation in a national cohort study: REasons for Geographic And Racial Differences in Stroke (REGARDS).
    Thacker EL; Soliman EZ; Pulley L; Safford MM; Howard G; Howard VJ
    Ann Epidemiol; 2016 Aug; 26(8):534-539. PubMed ID: 27480477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in preventive procedures: comparisons of self-report and Medicare claims data.
    Fiscella K; Holt K; Meldrum S; Franks P
    BMC Health Serv Res; 2006 Sep; 6():122. PubMed ID: 17010195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic Variation and Disparities in Total Joint Replacement Use for Medicare Beneficiaries: 2009 to 2017.
    Thirukumaran CP; Cai X; Glance LG; Kim Y; Ricciardi BF; Fiscella KA; Li Y
    J Bone Joint Surg Am; 2020 Dec; 102(24):2120-2128. PubMed ID: 33079898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.
    Gerber BS; Cho YI; Arozullah AM; Lee SY
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):136-45. PubMed ID: 20439063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining Black-White Disparities Among Medicare Beneficiaries in Assisted Living Settings in 2014.
    Fabius CD; Thomas KS
    J Am Med Dir Assoc; 2019 Jun; 20(6):703-709. PubMed ID: 30448156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.